Literature DB >> 9625298

Cell biology, clinicopathological profile, and classification of gastro-enteropancreatic endocrine tumors.

G Rindi1, C Capella, E Solcia.   

Abstract

Recent developments in the field of endocrine cell biology and pathology at both morphological and molecular levels are briefly outlined and discussed as a basis for endocrine tumor characterization. The main tools available for identifying the endocrine nature of the tumors, their pathogenetic interpretation. and experimental reproduction with special emphasis on tumor antecedents are reported. Based on this, classifications of endocrine tumors of the pancreas and gastrointestinal tract are developed, covering most clinical (hyperfunctional syndromes included), pathological, and biological patterns, with special emphasis on tumor prognosis.

Entities:  

Mesh:

Year:  1998        PMID: 9625298     DOI: 10.1007/s001090050233

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  9 in total

1.  Cytological Ki-67 in pancreatic endocrine tumors: a new "must"?

Authors:  Giulia Franchi; Marco F Manzoni
Journal:  Gland Surg       Date:  2014-11

2.  Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation.

Authors:  H Tönnies; M R Toliat; C Ramel; U F Pape; H Neitzel; W Berger; B Wiedenmann
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

3.  Regression of liver metastases of occult carcinoid tumor with slow release lanreotide therapy.

Authors:  Marta Bondanelli; Maria Rosaria Ambrosio; Maria Chiara Zatelli; Luigi Cavazzini; Laura Al Jandali Rifa'y; Ettore C degli Uberti
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

4.  Transarterial chemoembolization with miriplatin-lipiodol emulsion for neuroendocrine metastases of the liver.

Authors:  Jin Iwazawa; Shoichi Ohue; Keigo Yasumasa; Takashi Mitani
Journal:  World J Radiol       Date:  2010-12-28

5.  Expression of somatostatin receptor subtypes 1 to 5 in tumor tissue and intratumoral vessels in malignant endocrine pancreatic tumors.

Authors:  Marie-Louise Fjällskog; Eva Ludvigsen; Mats Stridsberg; Kjell Oberg; Barbro Eriksson; Eva T Janson
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

6.  Human Insulinomas: Clinical, Cellular, and Molecular Aspects.

Authors:  Paul Komminoth; Philipp U. Heitz; Jürgen Roth
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

Review 7.  Histogenesis and natural history of gut neuroendocrine tumors: present status.

Authors:  Enrico Solcia; Alessandro Vanoli
Journal:  Endocr Pathol       Date:  2014-06       Impact factor: 3.943

8.  The importance of preoperative localisation procedures in organic hyperinsulinism--experience in 67 patients.

Authors:  Klaus Kaczirek; Ahmed Ba-Ssalamah; Wolfgang Schima; Bruno Niederle
Journal:  Wien Klin Wochenschr       Date:  2004-06-30       Impact factor: 1.704

9.  Diffuse nesidioblastosis diagnosed on a Ga-68 DOTATATE positron emission tomography/computerized tomography.

Authors:  Sasikumar Arun; Bhagwant Rai Mittal; Jaya Shukla; Anish Bhattacharya; Praveen Kumar
Journal:  Indian J Nucl Med       Date:  2013-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.